CPIX CUMBERLAND PHARMACEUTICALS INC
Price Chart
Executive Summary
Cumberland Pharmaceuticals Inc. (CPIX) filed a Definitive Additional Proxy Statement (DEFA14A) for its 2026 Annual Meeting of Shareholders, scheduled for April 21, 2026. The filing solicits votes on the re-election of two director nominees (Kenneth Krogulski and Caroline Young), ratification of the appointment of Carr, Riggs Ingram, L.L.C. as independent auditors, advisory approval of executive compensation, and the frequency of future advisory votes on executive pay. The board recommends voting in favor of all proposals.
Actionable Insight
No immediate trading implications. Monitor for any unexpected opposition or shareholder activism ahead of the vote, though none is indicated in this filing. The next material event to watch is the company's 2025 Form 10-K, referenced in the proxy materials.
Key Facts
- Annual meeting date: April 21, 2026
- Record date for voting: February 27, 2026
- Director nominees: Kenneth Krogulski and Caroline Young
- Proposal to ratify Carr, Riggs Ingram, L.L.C. as independent auditors
- Advisory vote on executive compensation (say-on-pay)
- Advisory vote on frequency of say-on-pay votes (board recommends every three years)
- Filed by the registrant (company management)
Financial Impact
No direct financial impact from the proxy proposals
Risk Factors
- Low risk of shareholder opposition given routine nature of proposals
- Potential for future governance concerns if executive compensation becomes excessive relative to performance
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001087294-26-000027 |
| Document: 0001087294-26-000027-index-headers.html | 0001087294-26-000027 |
| Document: 0001087294-26-000027-index.html | 0001087294-26-000027 |
| Document: 0001087294-26-000027.txt | 0001087294-26-000027 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 26, 2026
14d ago
|
DEFM14A
| $5.77 $5.77 | · 0.00% | ▼ −1.21% | $5.72 (−0.87%) |
|
Apr 23, 2026
6w ago
|
DEFA14A / 8-K
| $3.90 $4.21 | ▲ +7.95% | ▲ +6.47% | $5.72 (+46.67%) |
|
Mar 9, 2026
13w ago
|
DEFA14A
| $3.16 $3.01 | ▼ −4.75% | ▼ −3.84% | $5.72 (+81.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access